LinkedIn Profile

Access Clovis Oncology historical Linkedin company profile data on number of followers, employee headcount and more

Records

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Ticker Sector Ticker Industry
nasdaq:clvs 904367 Jul 20th, 2019 12:00AM Clovis Oncology 11K 489.00 Open Biotechnology Jul 20th, 2019 03:11PM Jul 20th, 2019 03:11PM Founded in 2009, Clovis Oncology (NASDAQ: CLVS) is a commercial-stage biotechnology company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Our product development programs generally target specific subsets of cancer, and we aim to simultaneously develop, with partners, diagnostic tools intended to direct a compound in development to the patients most likely to benefit from their use. Through these collaborations, Clovis has the flexibility to choose the most appropriate technology for each program, and the expertise to gain regulatory approvals and support global commercialization that will parallel Clovis’ regulatory and commercialization paths. We believe this approach to precision medicine—to deliver the right drug to the right patient at the right time—represents the future of cancer therapy. Clovis Oncology’s management team has extensive experience in the development of novel cancer therapies and a shared commitment to the company’s vision. Clovis Oncology is headquartered in Boulder, Colorado. Please visit www.clovisoncology.com for more information, including additional office locations in the U.S. and Europe. Open oncology drug development, companion diagnostics, biotechnology Open 5500 Flatiron Parkway Boulder CO US 80301 Health Care Pharmaceuticals & Biotechnology
nasdaq:clvs 904367 Jul 19th, 2019 12:00AM Clovis Oncology 11K 489.00 Open Biotechnology Jul 18th, 2019 10:15PM Jul 18th, 2019 10:15PM Founded in 2009, Clovis Oncology (NASDAQ: CLVS) is a commercial-stage biotechnology company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Our product development programs generally target specific subsets of cancer, and we aim to simultaneously develop, with partners, diagnostic tools intended to direct a compound in development to the patients most likely to benefit from their use. Through these collaborations, Clovis has the flexibility to choose the most appropriate technology for each program, and the expertise to gain regulatory approvals and support global commercialization that will parallel Clovis’ regulatory and commercialization paths. We believe this approach to precision medicine—to deliver the right drug to the right patient at the right time—represents the future of cancer therapy. Clovis Oncology’s management team has extensive experience in the development of novel cancer therapies and a shared commitment to the company’s vision. Clovis Oncology is headquartered in Boulder, Colorado. Please visit www.clovisoncology.com for more information, including additional office locations in the U.S. and Europe. Open oncology drug development, companion diagnostics, biotechnology Open 5500 Flatiron Parkway Boulder CO US 80301 Health Care Pharmaceuticals & Biotechnology
nasdaq:clvs 904367 Jul 18th, 2019 12:00AM Clovis Oncology 11K 489.00 Open Biotechnology Jul 18th, 2019 02:00PM Jul 18th, 2019 02:00PM Founded in 2009, Clovis Oncology (NASDAQ: CLVS) is a commercial-stage biotechnology company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Our product development programs generally target specific subsets of cancer, and we aim to simultaneously develop, with partners, diagnostic tools intended to direct a compound in development to the patients most likely to benefit from their use. Through these collaborations, Clovis has the flexibility to choose the most appropriate technology for each program, and the expertise to gain regulatory approvals and support global commercialization that will parallel Clovis’ regulatory and commercialization paths. We believe this approach to precision medicine—to deliver the right drug to the right patient at the right time—represents the future of cancer therapy. Clovis Oncology’s management team has extensive experience in the development of novel cancer therapies and a shared commitment to the company’s vision. Clovis Oncology is headquartered in Boulder, Colorado. Please visit www.clovisoncology.com for more information, including additional office locations in the U.S. and Europe. Open oncology drug development, companion diagnostics, biotechnology Open 5500 Flatiron Parkway Boulder CO US 80301 Health Care Pharmaceuticals & Biotechnology
nasdaq:clvs 904367 Jul 17th, 2019 12:00AM Clovis Oncology 11K 489.00 Open Biotechnology Jul 17th, 2019 08:42AM Jul 17th, 2019 08:42AM Founded in 2009, Clovis Oncology (NASDAQ: CLVS) is a commercial-stage biotechnology company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Our product development programs generally target specific subsets of cancer, and we aim to simultaneously develop, with partners, diagnostic tools intended to direct a compound in development to the patients most likely to benefit from their use. Through these collaborations, Clovis has the flexibility to choose the most appropriate technology for each program, and the expertise to gain regulatory approvals and support global commercialization that will parallel Clovis’ regulatory and commercialization paths. We believe this approach to precision medicine—to deliver the right drug to the right patient at the right time—represents the future of cancer therapy. Clovis Oncology’s management team has extensive experience in the development of novel cancer therapies and a shared commitment to the company’s vision. Clovis Oncology is headquartered in Boulder, Colorado. Please visit www.clovisoncology.com for more information, including additional office locations in the U.S. and Europe. Open oncology drug development, companion diagnostics, biotechnology Open 5500 Flatiron Parkway Boulder CO US 80301 Health Care Pharmaceuticals & Biotechnology
nasdaq:clvs 904367 Jan 15th, 2019 12:00AM Clovis Oncology 9.8K 455.00 Open Biotechnology Jan 14th, 2019 09:17PM Jan 14th, 2019 09:17PM Open Health Care Pharmaceuticals & Biotechnology
nasdaq:clvs 904367 Jan 14th, 2019 12:00AM Clovis Oncology 9.8K 455.00 Open Biotechnology Jan 14th, 2019 01:33PM Jan 14th, 2019 01:33PM Open Health Care Pharmaceuticals & Biotechnology
nasdaq:clvs 904367 Jan 13th, 2019 12:00AM Clovis Oncology 9.8K 455.00 Open Biotechnology Jan 12th, 2019 09:17PM Jan 12th, 2019 09:17PM Open Health Care Pharmaceuticals & Biotechnology
nasdaq:clvs 904367 Jan 12th, 2019 12:00AM Clovis Oncology 9.8K 455.00 Open Biotechnology Jan 12th, 2019 06:59AM Jan 12th, 2019 06:59AM Open Health Care Pharmaceuticals & Biotechnology
nasdaq:clvs 904367 Jan 11th, 2019 12:00AM Clovis Oncology 9.8K 454.00 Open Biotechnology Jan 11th, 2019 01:05AM Jan 11th, 2019 01:05AM Open Health Care Pharmaceuticals & Biotechnology
nasdaq:clvs 904367 Jan 10th, 2019 12:00AM Clovis Oncology 9.7K 454.00 Open Biotechnology Jan 10th, 2019 12:10AM Jan 10th, 2019 12:10AM Open Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.